Diagnostic significance of combining telomerase activity with CYFRA21-1 level in differentiating malignant pleural effusion caused by lung cancer from benign pleural effusion

Chinese Journal of Lung Cancer

Volumn 13, Issue 6, 2010, Pages 652-654

  Li, Hongmei ^a,b   Fu, Junhua ^b   Xiu, Yuande ^b   Zhou, Qinghua ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b QINGDAO UNIVERSITY   (China)

Author keywords

CYFRA21 1; Differential diagnosis; Pleural effusion; Telomerase

Indexed keywords

CYTOKERATIN 19 FRAGMENT; TELOMERASE;

ARTICLE; BENIGN TUMOR; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; ENZYME ACTIVITY; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; PLEURA EFFUSION; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; TELOMERIC REPEAT AMPLIFICATION PROTOCOL;

AGED; ANTIGENS, NEOPLASM; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; KERATIN-19; MALE; MIDDLE AGED; PLEURAL EFFUSION; PLEURAL EFFUSION, MALIGNANT; TELOMERASE;

EID: 77953632448     PISSN: 10093419     EISSN: 19996187     Source Type: Journal    
DOI: 10.3779/j.issn.1009-3419.2010.06.017     Document Type: Article

References (10)

1. Gu P, Huang G, Chen Y, et al. Diagnostic utility of pleural f luid carcinoembryonic antigen and CYFRA21-1 in patients with pleural effusion: a systematic review and meta-analysis. J Clin Lab Anal, 2007, 21(6): 398-405.
2. Maneechotesuwan K, Lertworawiwat A, Tscheikuna J, et al. Comparison of telomerase activity between malignant and tuberculous pleural effusions. J Med Assoc Thai, 2006, 89(5): 46-54.
3. Yao K, Yu ZB, Min JX, et al. Clinical significance of telomerase activity in lung cancer. Chin J Lung Cancer, 2003, 6(5): 364-366. 2003, 6(5): 364-366. (Pubitemid 37295452)
4. Liang QL, Shi HZ, Qin XJ, et al. Diagnostic accuracy of tumour markers for malignant pleural effusion: a meta-analysis. Thorax, 2008, 63(1): 35-41.
5. Topolcan O, Holubec L, Polivkova V, et al. Tumor markers in pleural effusions. Anticancer Res, 2007, 27(4A): 1921-1924.
6. Shu J, Sun GY, Liu AP, et al. Diagnostic accuracy of human telomerase reverse transcriptase mRNA in malignant pleural effusions: A preliminary report for in situ hybridization detection. Clin Chim Acta, 2007, 381(2): 131-135.
7. Wu GP, Ba J, Zhao YJ, et al. Diagnostic value of CEA, CYFRA 21-1, NSE and CA 125 assay in serum and pleural effusion of patients with lung cancer. Acta Cytol, 2007, 51(4): 679-680.
8. Li CS, Cheng BC, Ge W, et al. Clinical value of CYF!21-1, NSE, CA15-3, CA19-9 and CA125 assay in the elderly patients with pleural effusions. Int J Clin Pract, 2007, 61(3): 444-448. (Pubitemid 46271251)
9. Zhang J, Ge XH. The value of telomerase activity in diagnostic benign and malignant pleural effusion. Ningxia Med J, 2006, 28(1): 10-12.
10. Shitrit D, Zingerman B, Shitrit AB, et al. Diagnostic value of CYF! 21-1, CEA, CA 19-9, CA 15-3, and CA 125 assays in pleural effusions: analysis of 116 cases and review of the literature. Oncologist, 2005, 10(7): 501-507. (Pubitemid 41266331)